Berinstein, N. L., Karkada, M., Oza, A. M., Odunsi, K., Villella, J. A., Nemunaitis, J. J., . . . Mansour, M. (2015). Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. Oncoimmunology.
Stile di citazione ChicagoBerinstein, Neil L., et al. "Survivin-targeted Immunotherapy Drives Robust Polyfunctional T Cell Generation and Differentiation in Advanced Ovarian Cancer Patients." Oncoimmunology 2015.
Citazione MLABerinstein, Neil L., et al. "Survivin-targeted Immunotherapy Drives Robust Polyfunctional T Cell Generation and Differentiation in Advanced Ovarian Cancer Patients." Oncoimmunology 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.